NIH grants $84M to NYU Langone for ischemia comparative effectiveness study
This article was originally published in Scrip
Executive Summary
In one of the largest comparative effectiveness research grants ever awarded by the National Institutes of Health (NIH), the agency has bestowed $84 million to NYU Langone Medical Center to evaluate whether a routine early invasive strategy (INV) with cardiac catheterization followed by revascularization plus optimal medical therapy (OMT) and lifestyle changes is superior to a conservative strategy of OMT, reserving invasive procedures for failure of the strategy in patients with moderate to severe ischemia.